Table 2 Comparison of baseline characteristics between patients in the rt-PA and no rt-PA groups
From: Capsular warning syndrome: clinical analysis and treatment
rt-PA group (27) | no rt-PA group (45) | P* | |
|---|---|---|---|
Age, year, (mean SD) | 64.69 ± 7.11 | 67.24 ± 8.27 | 0.179 |
NIHSS score at onset, median (IQR) | 7 (4–8) | 8 (6–9) | 0.088 |
Mean number of episodes, n (%) | 4.74 ± 2.31 | 5.76 ± 2.44 | 0.142 |
Mean duration, minutes (mean SD) | 24.4 ± 11.64 | 23.91 ± 11.08 | 0.926 |
ABCD2 score, median (IQR) | 5 (4–5) | 5 (4–5) | 0.967 |
Systolic pressure, mmHg (mean SD) | 165.15 ± 19.00 | 169.31 ± 24.81 | 0.340 |
Glucose, mmol/l (mean SD) | 5.72 ± 0.99 | 6.10 ± 1.10 | 0.124 |
Men, n (%) | 18 (66.67) | 26 (57.78) | 0.789 |
BMI ≥ 24 kg/m, n (%) | 7 (25.93) | 9 (20.00) | 0.558 |
Hypertension, n (%) | 20 (74.07) | 32 (71.11) | 0.786 |
Currently smokers, n (%) | 8 (29.63) | 18 (40.00) | 0.375 |
Diabetes, n (%) | 11 (40.74) | 16 (35.57) | 0.660 |
Hyperlipidemia, n (%) | 17 (62.96) | 30 (66.67) | 0.749 |
Currently alcohol drinkers, n (%) | 9 (33.33 | 15 (33.33) | 1.00 |
Family history of stroke, n (%) | 7 (25.93) | 9 (20.00) | 0.558 |
Medications use | |||
Antiplatelet, n (%) | 8 (29.63) | 14 (31.11) | 0.895 |
Antihypertensive, n (%) | 12 (44.44) | 19 (42.22) | 0.854 |
Lipid-lowering medications, n (%) | 11 (40.74) | 25 (55.56) | 0.224 |